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Compound 1 {N-[1(R)  [(1,2-dihydro-1-methylsulfonylspiro[3H-indole-3,4'-piperidin]-
1'-yl)carbonyl]-2-(phenylmethyloxy)ethyl]-2-amino-2-methylpropanamide}(MW 528) is an
orally-active growth hormone secretagogue (GHS). As part of a continual effort to analyze the
ESI/MS and MSn data of novel drugs, the ESI/MS and MS/MS data of protonated 1 (m/z 529)
are analyzed and reported here. The analyses reveal that under low-energy collision-induced
dissociation (CID) in an ion trap or a quadrupole collision cell, protonated 1 undergoes a
gas-phase rearrangement to form protonated 3 (m/z 357) which competes with the y- and
b-type product ions during the amide bond cleavages of protonated 1. It is proposed that when
the b-type ion is formed by cleavage of the piperidine amide bond, piperidine (a neutral
species) and the b-ion (a cation) form an ion-neutral complex. In this complex, piperidine
functions as a nucleophile to attack the benzylic carbon of the b-ion, and the protonated ether
group in the b-ion acts as a leaving group, which results in the migration of the benzylic group
to the piperidine amine to form protonated 3. Protonated 2 (an analog of 1) was studied under
the same experimental conditions. The results show that protonated 2 undergoes a similar
rearrangement to form protonated 3. While this rearrangement is a relatively minor fragmen-
tation process for protonated 1, it is a predominant process for protonated 2. This phenomenon
is explained in terms of the proposed ion-neutral-complex mechanism. (J Am Soc Mass
Spectrom 2002, 13, 371–377) © 2002 American Society for Mass Spectrometry
Compound 1 {N-[1(R)  [(1,2-dihydro-1-methylsulfonylspiro[3H-indole-3,4'-piperidin]-1'-yl)carbonyl]-2-(phenylmethyloxy)ethyl]-
2-amino-2-methylpropanamide} (MW 528) is an orally-
active growth hormone secretagogue (GHS). It has two
amide bonds and can be considered to be a modified
dipeptide. This compound has been evaluated in clini-
cal studies as a potential alternative to GH replacement
therapy [1].
Recently, electrospray ionization mass spectrometry
(ESI/MS) and tandem mass spectrometry (MSn) have
been applied to many areas of drug discovery and
development [2, 3]. The successful application of these
techniques requires a thorough understanding of the
ESI/MS and MSn data of the drugs under investigation.
As part of a continual analysis of the ESI/MS and MSn
data of representative, diverse drugs [4–8], the MS/MS
data of protonated 1 are analyzed in detail in this
report. Although LC/MS/MS has been applied to the
determination of this compound in human plasma, the
MS/MS data have not been carefully analyzed [9].
Previous studies [4–8] have demonstrated that novel
drugs could have novel gas-phase chemistry. Indeed,
the analysis of the MS/MS data of protonated 1 unveils
some of the remarkable gas-phase chemistry of proton-
ated 1, which includes a gas-phase rearrangement that
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competes with the formation of y- and b-type ions
during the cleavage of the amide bonds of this ion.
It is well-known that protonated ions often undergo
gas-phase rearrangement [10]. For example, benzyl
group migration from benzyloxycarbonyl to amidic
nitrogens in CID of protonated peptides with Boc
protecting groups has been documented [11, 12]. Sev-
eral mechanisms have been proposed, such as a cyclic
transition state in which an amide nitrogen attacks the
benzylic carbon as a nucleophile [11] and a nominal
four-membered-ring intermediate [12]. More recently, a
novel gas-phase rearrangement of a farnesyl transferase
inhibitor shown in eq 1 has been reported [8]. It has
been proposed that this rearrangement (migration of a
substituted benzyl group) is initiated by gas-phase
intramolecular nucleophilic displacement [8].
(1)
In this study, another remarkable gas-phase rearrange-
ment involving benzyl group migration is described. In
MS/MS experiments with a quadrupole ion trap or a
collision cell of a quadrupole time-of-flight (Q-TOF)
instrument, protonated 1 (m/z 529) and its analog 2 (m/z
444) rearrange to protonated 3 (m/z 357). These results
provide examples of benzyl group migration from ether
groups to amidic nitrogens under low-energy CID,
which have not been reported before. The rearrange-
ment cannot be well explained by the above-mentioned
mechanisms as described in recent literature. In the past
two decades, ion-neutral complexes have been noted in
many gas-phase rearrangements of organic ions [13–
15]. It is proposed that the rearrangements of proton-
ated 1 and 2 also involve ion-neutral complexes, each of
which contains a b-type ion and a neutral piperidine
formed during the cleavage of the protonated piperi-
dine amide bond. In the complexes, the piperidine
functions as a nucleophile to attack the benzylic carbon
of the b-type ion while protonated ether of the b-type
ion acts as a leaving group, resulting in the migration of
the benzylic group to the piperidine amine in proton-
ated 1 and 2 to form 3.
Of note is the finding that the product ions of
protonated 1 (or 2) formed in an ion trap are the same
as the product ions formed in Q-TOF although the
relative yield of each product ion varies between the
two instruments. The rearrangement is more prominent
in an ion trap; therefore, the rearrangement described in
this paper is based on the results of an ion trap. The
results from Q-TOF are also included to assist in inter-
pretation because this instrument gives accurate mass
measurement for product ions.
Experimental
The quadrupole ion trap experiments were performed
using a Finnigan LCQ (San Jose, CA) instrument
equipped with a Finnigan MAT electrospray interface
in the positive ionization mode. After protonated ions
were generated by electrospray and injected into the ion
trap, the ions of the mass-to-charge ratio (m/z) of
interest were isolated while all other ions were ejected
from the ion trap before the MSn stage of the experi-
ment. The selected ions were then resonantly excited in
the presence of helium (pressure about 105 torr) to
effect CID. The CID conditions were gZ  0.25 and 30
ms. The relative collision energy (or resonance energy)
settings were 25 to 40%. The collision energy was
calibrated using the Finnigan procedure. The product
ions formed from CID produced an MS/MS spectrum.
MSn experiments were conducted by isolating product
ions of the desired m/z from a previous state of MS/MS,
and then resonantly exciting those ions. The product
ions in these stages produced an MSn spectrum.
The quadrupole time-of-flight experiments were per-
formed using a Micromass (Manchester, UK) Q-TOF-2
spectrometer operated in an electrospray positive ion
mode with the cone voltage at 30 volts. CID was carried
out using argon as the collision gas with collision
energies from 20 to 45 eV.
Compounds 1, 2, and 4 were obtained from Chemical
Data of Merck Research Laboratories (Rahway, NJ), and
used without further purification. Compound 3 was
made by a reaction of 4 with benzyl bromide in DMF
[16]. Compound 3 was verified by accurate mass mea-
surement and proton NMR. The NMR data showed that
the chemical shift ()4.8 (singlet) for the methylene
protons of benzyl bromide changed to 4.7 (singlet) for
the corresponding methylene protons of 3 while the
NMR data for all the other protons of 4 and benzyl
bromide were little changed in 3.
The samples were prepared by dissolving approxi-
mately 5 mg of each compound into 100 ml water.
Accordingly, the deuterated samples were prepared by
dissolving 5 mg of each compound into 100 ml D2O.
The samples were delivered into the LCQ instrument
or Micromass Q-TOF-2 instrument by infusion at 3
l/min using a Harvard Apparatus Pump 11.
Results and Discussion
CID of Protonated 1
A representative MS/MS spectrum of protonated 1 (m/z
529) obtained using Finnigan LCQ is depicted in Figure
1, which shows six product ions at m/z 444, 357, 267,
263, 235, and 188. The proposed structures of these six
product ions are shown in Scheme 1. The structures are
fully supported by the accurate masses obtained using
Micromass QTOF-2. Table 1 shows the comparison of
the masses determined by Micromass QTOF-2 and the
actual masses of the proposed structures. The relative
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errors are all less than 10 ppm. The measurement was
repeated five times and in all the measurements, the
relative errors were found to be less than 10 ppm. Because
the compositions of these product ions must be within
the formula of protonated 1 (C0–27H0–37N0–4O0–5S0–1),
the compositions in terms of the accurate masses were
calculated within this formula. The results indicate that
the proposed structures have the only reasonable com-
positions.
The six product ions are formed by charge-induced
competing processes which are dependent on protona-
tion sites. Because compound 1 has a pKa value of 7.4
assigned to the primary amine, the initial protonation
site should be at the primary amine. However, proton
migration can occur upon CID, and other basic sites can
be protonated according to the mobile proton hypoth-
esis [17, 18]. The protonation of the amide group of
2-amino-2-methyl-propanamide results in the forma-
tion of the ion at m/z 444. The formation of this ion
resembles that of a y-ion of a protonated peptide. The
structure of this ion is confirmed by a match of the
product ion spectra of this ion (MS3 experiments) and
the product ion spectra of protonated 2 (the neutral
precursor of the ion at m/z 444) (MS2 experiments). The
protonation of the piperidine amide group gives rise to
the ion at m/z 267 (also a y-ion formation mechanism).
The structure of this ion is confirmed by a match of the
product ion spectra of this ion (MS3 experiments) and
the product ion spectra of protonated 4 (the neutral
precursor of the ion at m/z 267) (MS2 experiments). The
MS3 results of the ion at m/z 267 show that the ion at m/z
188 is a major product ion of the ion at m/z 267.
According to the accurate mass results (Table 1), the ion
at m/z 188 is formed by the loss of the SO2CH3 radical
from the ion at m/z 267. Based on Proton Affinities
(PAs), it is expected that the secondary amine, rather
than the amide, of the ion at m/z 267 would be proton-
ated. As a result, the m/z 188 ion would be a novel
distonic radical ion with a separate nitrogen-centered
cation and nitrogen-centered radical. However, if an
H-migration from the amine to the amide occurred
simultaneously with the homolytic cleavage of the S™N
bond, an amine radical cation at m/z 188 would be
formed. This H-migration seems less likely since the
difference in PAs between the amine and the amide is
estimated to be greater than 0.5 eV (or 50 kJmol1) [19],
a proposed value beyond which H-exchanges no longer
occur in the unimolecular decomposition of protonated
species [20, 21]. When the piperidine amide is proton-
Figure 1. An ESI/MS/MS spectrum of protonated 1 obtained
using Finnigan LCQ.
Scheme 1 Proposed structures for the six major product ions
observed in MS/MS of protonated 1. The data in parentheses are
those observed in MS/MS of deuterated 1.
Table 1. Comparison of accurate masses determined by
Micromass QTOF-2 and actual masses for the proposed
structures of the six product ions of protonated 1 (C27H37N4O5S)
Product ions Mass (QTOF-2) Actual mass Relative error
C23H30N3O4S
(m/z 444)
444.1948 444.1957 2ppm
C20H25N2O2S
(m/z 357)
357.1650 357.1637 4ppm
C13H19N2O2S
(m/z 267)
267.1163 267.1167 1ppm
C14H19N2O3
(m/z 263)
263.1386 263.1396 4ppm
C13H19N2O2
(m/z 235)
235.1463 235.1447 6ppm
C12H16N2
(m/z 188)
188.1304 188.1313 5ppm
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ated, a heterolytic C™N bond cleavage of this group
gives rise to the ion at m/z 263 by elimination of a
neutral amine. The formation of this ion resembles a
b2-ion formation of protonated peptides. Since the dom-
inant view favors the idea that b2-ions have a five-
membered ring structure (protonated oxazolone) [22],
the structure of the ion at m/z 263 is assigned to an
oxazolonium cation. MS3 of the ion at m/z 263 yields an
abundant ion at m/z 235 arising by CO loss and a
smaller ion at m/z 219 arising by CO2 loss. These results
provide strong evidence for the assignment. Particu-
larly, the CO2 loss is considered to be diagnostic of a
protonated oxazolone [23]. Loss of a CO group from the
ion at m/z 263 produces the ion at m/z 235 (an a-type of
ion).
In addition, there is a unique ion at m/z 357, which
cannot be rationalized without invoking skeletal rear-
rangement. The proposed structure (protonated 3) for
this ion is formed by the migration of the benzyl cation
from the ether group to the piperidine amide nitrogen
followed by the elimination of the keto with the rest of
the molecule. The rearrangement, although a minor
process, is significant since the rearrangement competes
with the formations of y- and b-ions. The rearrange-
ment can become a predominant fragmentation process
for analogs of 1 such as protonated protonated 2 (see
below).
CID of the Rearrangement Ion at m/z 357 and
Protonated 3
Convincing evidence for the structural assignment of
the ion at m/z 357 comes from accurate mass measure-
ments (by Micromass Q-TOF-2) of the product ions of
this ion (generated by source CID of protonated 1) and
protonated 3 (the neutral precursor of the ion at m/z
357). Five measurements show that both the number
and the accurate mass of the product ions of this ion are
in excellent agreement with those of protonated 3. A set
of measurement results of the main product ions are
shown in Table 2 to demonstrate this point.
It is noteworthy that the accurate mass of the ion at
m/z 278 indicates that it is formed from the loss of the
SO2CH3 radical from the ion at m/z 357. According to
the accurate mass, the ion at m/z 91 has the elemental
composition of C7H7
, which is either the benzyl or its
isomer-tropylium cation [24]. The presence of both
SO2CH3 and benzyl groups in the ion at m/z 357 is
consistent with the assigned structure of this ion.
Proposed Rearrangement Pathway for Protonated 1
The rearrangement of protonated 1 to the ion at m/z 357
appears to follow a four-membered-ring intermediate
as shown in Scheme 2. This type of intermediate has
been proposed to explain many other even-electron-ion
rearrangements [10] as well as the benzyl group migra-
tion of protonated peptides with Boc protecting groups
Table 2. Comparison of the product ions of the ion at m/z 357
generated from source CID of protonated 1 and from its
protonated neutral precursor (3)
Product ions Source CID Protonated 3 Difference
m/z 278 278.1793 278.1783 1 mDa
m/z 221 221.1202 221.1224 2 mDa
m/z 187 187.1237 187.1277 4 mDa
m/z 170 170.0980 170.0984 1 mDa
m/z 144 144.0799 144.0830 3 mDa
m/z 131 131.0769 131.0751 2 mDa
m/z 91 91.0541 91.0553 1 mDa
Scheme 2 Nominal four-membered-ring transition state for the
rearrangement of protonated 1 and 2.
Scheme 3 A proposed rearrangement mechanism for the forma-
tion of the ion at m/z 357 from protonated 1. The data in
parentheses are for deuterated 1.
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[12]. However, those intermediates are unfavorable
with regard to orbital-symmetry considerations [25]. It
has been noted that these rearrangements may proceed
with involvement of ion-molecule complexes [20].
Another proposed mechanism for the rearrangement
of protonated 1 to the ion at m/z 357 involves an
intramolecular SN2 type reaction between the piperi-
dine amide nitrogen and the benzylic carbon [26].
Similar mechanisms have been proposed for the benzyl
migration of protonated peptides with Boc protecting
groups [11]. These mechanisms are considered to be less
plausible because an amide nitrogen is not considered
to be a nucleophile [27].
Recently, ion-neutral complexes have been found to
be involved in many gas-phase rearrangements [14].
Specifically, Harrison and co-workers have demon-
strated that upon low-energy CID, fragmentations of
protonated amide proceed by way of ion-neutral com-
plexes [28]. Thus, it is reasonably proposed that the
rearrangement of protonated 1 (a protonated amide)
proceeds by way of ion-neutral complexes. As outlined
in Scheme 3, when the piperidine amide group is
protonated, the C™N bond cleaves to form an ion-
neutral complex consisting of the b-type ion at m/z 263
and a neutral piperidine derivative. This complex can
be facilitated by several non-covalent-bonding interac-
tions (hydrogen bonding, charge-dipole, dipole-dipole,
etc). Since many reactions and rearrangements may
occur within ion-neutral complexes, it is proposed that
in this complex, the rearrangement to form the ion at
m/z 357 competes with the b-type ion at m/z 263 and the
y-type ion at m/z 267. Namely, the piperidine amine acts
as a nucleophile to attack the benzylic carbon of the
b-ion, and protonated ether of the b-ion acts as a leaving
group, leading to the migration of the benzylic group to
the piperidine amine to form the ion at m/z 357. Such a
SN2 reaction is facilitated by the fact that piperidine is a
very strong nucleophile with nCH3I being 7.30 [29] and
the fact that protonated ether, like protonated alcohol, is
a gas-phase leaving group [30].
CID of d4  1
The proposed ion-neutral-complex mechanism for pro-
tonated 1 was checked by MS/MS of d4  1 at m/z 533
in which the four changeable protons (one amide and
three amine protons) were replaced by deuterium. The
six product ions for d4 1 (not shown), observed at m/z
447, 358, 269, 266, 238, and 190, are consistent with the
structures proposed for protonated 1 (see Scheme 1).
However, it was observed that the rearrangement ion,
both in an ion trap and in a collision cell of Q-TOF,
shows significant isotopic scrambling. It is difficult to
explain this isotopic scrambling by the mechanisms of
either a concerted four-membered-ring intermediate
[12] or a cyclic transition state [11]. However, a plausi-
ble explanation for this isotopic scrambling may be the
existence of ion-neutral complexes in the rearrangement
process. As is well documented, the most common
reactions occurring in ion-neutral complexes are H
transfers and H exchanges [14], which can lead to
isomerization and isotopic scrambling.
CID of Protonated 2
Protonated 2 (an analog of 1) was studied under the
same experimental conditions to determine whether or
not an analog of 1 undergoes the same rearrangement.
A representative MS/MS spectrum of protonated 2
obtained using Finnigan LCQ is depicted in Figure 2.
The figure shows six major product ions at m/z 426, 365,
357, 336, 267 and 150. The structures for these product
ions are proposed in Scheme 4. It is noteworthy that the
Figure 2. An ESI/MS/MS spectrum of protonated 2 obtained
using Finnigan LCQ.
Scheme 4 Proposed structures for the six major product ions
observed in MS/MS of protonated 2.
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same rearrangement ion at m/z 357 was indeed ob-
served. This was verified by a comparison of the
product ions of this ion (MS3 experiments) with the
product ions of protonated 3 (MS2 experiments), as well
as with the product ions of the ion at m/z 357 observed
in CID of protonated 1 (MS3 experiments). The product
ion at m/z 365 is formed by the elimination of the
SO2CH3 radical from protonated 2. The ion at m/z 336 is
formed by the elimination of (C6H5)CH2OH from pro-
tonated 2. This elimination is possibly facilitated by the
participation of the neighboring amine group [27]. In
fact, the loss of (C6H5)CH2OH was too weak to be seen
in CID of protonated 1 that does not have a neighboring
amine group. The ion at m/z 267 is a y-type ion, and the
ion at m/z 150 is an a-type ion. These assignments are
supported by accurate mass measurement using Q-
TOF-2 (not shown). The product ion at m/z 426 is
formed by dehydration (H2O) from protonated 2. An
accurate mass obtained from QTOF-2 for this ion is
426.1888 Da, giving the relative error of 9 ppm for
dehydration (the actual mass is 426.1851 Da). Repeated
measurements gave similar results. These results sup-
port the assignment for this ion. For protonated 2, the
rearrangement competes with all these fragmentation
processes.
Interestingly, there is a striking difference between
the relative intensities of the rearrangement from pro-
tonated 1 and 2. The rearrangement is a minor process
of protonated 1 (Figure 1) while it is a predominant
process of protonated 2 (Figure 2). Since protonated 2 is
also a product ion (m/z 444) of protonated 1, it may be
argued that the rearrangement observed in CID of
protonated 1 occurs consecutively from the ion at m/z
444 rather than directly from protonated 1. This was
checked by a comparison of the intensity ratio (defined
as the rearrangement ion to the ion at m/z 444) for
protonated 1 and 2 under the same collision energies. It
is assumed that the ratio for protonated 1 should be
equal to or less than the ratio for protonated 2 if the
rearrangement of protonated 1 is from a consecutive
fragmentation of its product ion at m/z 444. It has been
found that the ratio increases as collision energy in-
creases. At higher collision energies, the ratio from
protonated 1 can be much higher than the ratio from
protonated 2. For example, at the collision energy of 45
eV using Micromass Q-TOF-2, the ratio was 9 from
MS/MS of protonated 1 compared to 1 from MS/MS of
protonated 2. Thus, direct rearrangement of protonated
1 under CID must contribute to some of the intensities
of the rearranged ion. Nevertheless, the rearrangement
is a minor process from protonated 1 whereas it is a
major process from protonated 2.
The difference in relative intensity of the rearrange-
ment ion for protonated 1 and 2 cannot be well ex-
plained by the mechanisms of a concerted four-mem-
bered-ring intermediate [12] or by a cyclic transition
state [11] since the structural difference between pro-
tonated 1 and 2 is in the R-group (see Scheme 2), which
is not in the reaction centers of these mechanisms. To
elaborate this point, several other species modified from
1 on the R-group have been made. It has been found
that the relative intensity of the rearrangement ion
could be dramatically affected by modifications of re-
mote sites of the R-group, which further argues against
these two mechanisms. On the other hand, the relative
yield of the rearrangement ion for protonated 1 and 2
can be well explained by the proposed ion-neutral
complex mechanism. Since the rearrangement is a SN2
type, it would be affected by both attacking nucleo-
philes and leaving groups. A comparison of the path-
ways for protonated 1 (Scheme 3) and 2 (Scheme 5)
indicates that the neutral piperidine (the nucleophile) is
the same, but the leaving groups of the two species are
different. The leaving group for protonated 1 is a
protonated ether group. Since the b-type ion in the
ion-neutral complex formed from protonated 1 is an
oxazolonium ion, the imine of which has a higher
proton affinity (about 9.1 eV) than the ether group
(about 8.1 eV), protonation of the ether group is less
favored than that of the imine group. As a result, the
rearrangement is a minor fragmentation process. On the
Scheme 5 A proposed rearrangement mechanism for the forma-
tion of the ion at m/z 357 from protonated 2.
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other hand, the leaving group in the b-type ion in the
ion-neutral complex formed from protonated 2 is likely
an acylium cation or a positively charged lactone group
(since an oxazolonium ion cannot be formed), which is
a much better leaving group. Thus, a more facile
rearrangement takes place. It has been found that when
the R-group is modified so that the b-type ions cannot
form oxazolonium ions, the rearrangement is a predom-
inant process, and vice versa.
Conclusion
This study demonstrates that protonated 1 and 2 un-
dergo a gas-phase rearrangement by a benzylic cation
migration from an ether group to the piperidine amine.
This rearrangement occurs during the cleavage of the
piperidine amide bond of these two species in an ion
trap or a quadrupole collision cell under low-energy
CID. The rearrangement competes with the formations
of y-, b- and/or a-type ions during the amide bond
cleavage. It is proposed that the rearrangement pro-
ceeds as a nucleophilic displacement reaction in an
ion-neutral complex. The study suggests that in the gas
phase under certain conditions, an amine group formed
from the cleavage of an amide bond in an amide-
containing species can be a nucleophile and undergo
nucleophilic displacement reaction in an ion-neutral
complex. The generality of this statement and the
conditions under which such reactions can occur have
yet to be further explored.
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